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Glaucoma is the leading cause of irreversible blindness in the world currently impacting 
66.8 million people. There are several different types of Glaucoma with the most common one 
being primary open-angle glaucoma (POAG). Patients suffering from POAG experience aqueous 
humor accumulation within the eye causing an increase of pressure called the Intraocular 
Pressure (IOP). The cause of this rise of IOP is due to poor outflow of aqueous humor through 
the trabecular meshwork (TM). The TM is a 3D matrix composed of collagen and 
glycosaminoglycans (GAGs) embedded with endothelial-like TM cells. TM cells physiology is 
impacted by the morphology of the environment they are cultured in. This causes TM cells to 
behave differently in vitro compared to in vivo. This lack of function makes it difficult to screen 
novel drugs accurately. The goal of this research was to create a 3D hydrogel model to more 
accurately mimic the native TM.   
The first step was to develop and test a procedure to produce GelMA and fabricate it into 
scaffolds. The second step was to determine the optimal underlying GelMA concentration to use 
and to test the mechanical strength and swelling capabilities of these scaffolds in the presence of 
GAGs. The final step was to seed TM cells onto the various GelMA scaffolds and study the 
effect each scaffold, in the presence of dexamethasone (Dex), had on proliferation, gene 
expression, and cell morphology. The result of which produced several different GelMA 











TABLE OF CONTENTS 
 
ABSTRACT ................................................................................................................................... iii 
LIST OF FIGURES ....................................................................................................................... vi 
LIST OF TABLES ........................................................................................................................ vii 
ACKNOWLEDGEMENTS ......................................................................................................... viii 
CHAPTER 1 INTRODUCTION ...................................................................................................1 
1.1   Glaucoma Background .................................................................................................1 
 1.2   Current Treatments ......................................................................................................2 
1.3   In Vitro Models of Trabecular Meshwork ...................................................................3 
1.4   Gelatin-Methacrylate as a 3D Substrate for TM Cell Growth .....................................4 
1.5   Application of Drug Studies ........................................................................................6 
1.6   Goal of Research ..........................................................................................................7 
1.6.1 Production of GelMA and Fabrication of Scaffolds .......................................7 
1.6.2 Characterizing Scaffolds .................................................................................7 
1.6.3 TM Culture on GelMA Scaffolds ...................................................................8 
CHAPTER 2 MATERIALS AND METHODS .............................................................................9 
2.1   Materials ......................................................................................................................9 
2.2   Production of GelMA ................................................................................................10 
2.3   Fourier Transform Infrared (FT-IR) Spectrum ..........................................................11 
2.4   Free Amine Assay ......................................................................................................11 
2.5   Fabrication of GelMA Scaffolds ................................................................................12 
2.6   Culturing TM Cells on GelMA Scaffolds ..................................................................12 




2.8   Swelling Characterization ..........................................................................................14 
2.9   Fluorescent Staining of TM Cells ..............................................................................14 
2.10 RNA Isolation and qPCR ...........................................................................................15 
2.11 Analysis Techniques Used .........................................................................................15 
CHAPTER 3 RESULTS AND DISCUSSIONS ..........................................................................16 
3.1   Measuring the Degree of Methacrylation ..................................................................16 
 3.1.1 FT-IR Spectrum Analysis .............................................................................16 
 3.1.2 Free Amine Assay Analysis ..........................................................................17 
3.2   Scaffolds Characterization .........................................................................................18 
 3.2.1 Underlying GelMA Wt.% Concentration Determined  ................................18 
 3.2.2 Storage Modulus Analysis of Each Scaffold Type .......................................21 
 3.2.3 Swelling Analysis .........................................................................................22 
3.3   Cell Studies ................................................................................................................23 
 3.3.1 Proliferation and Confocal Imaging Studies .................................................24 
 3.3.2 Analysis of Fibronectin Expression via qPCR ..............................................27 
CHAPTER 4 CONCLUSION ......................................................................................................30 
4.1   Summary ....................................................................................................................30 
4.2   Future Works .............................................................................................................32 










LIST OF FIGURES 
Figure 1.1 The outflow pathway of aqueous humor in the eye  ......................................................3 
 
Figure 3.1 FT-IR spectra of gelatin and GelMA ............................................................................16 
 
Figure 3.2  Proliferation of TM cells on varying concentrations of GelMA scaffolds  
over 3, 7 and 14 days using CCK8  .......................................................................19 
 
Figure 3.3  Fluorescently stained nuclei of TM cells stained with DAPI (blue) and imaged  
using confocal at 3 days, 7 days, and 14 days grown on 5%, 7%, and 
 10% GelMA scaffolds ...........................................................................................20 
 
Figure 3.4  Storage modulus of GelMA, GelMA/HA, GelMA/CS, and GelMA/CS/HA (n=4) ...22 
 
Figure 3.5  Swelling ratio for GelMA, GelMA/HA, GelMA/CS, and  GelMA/CS/HA  
scaffolds (n=3) at 1 day, 7 days, and 14 days ........................................................23 
 
Figure 3.6  (a) Comparison of proliferation across scaffold types in the  presence of Dex 
at week 1. (b) Comparison of proliferation across scaffold types in the  
presence of Dex at week 2 .....................................................................................24 
 
Figure 3.7  TM cells seeded on each scaffold type and cultured for 1 week,  then  
fixed and stained for DAPI (blue) and fibronectin (Red) and imaged  
with confocal at 10x and 60x magnification ..........................................................25 
 
Figure 3.8  TM cells seeded on each scaffold type and cultured for 2 week,  then fixed 
and stained for DAPI (blue) and fibronectin (Red) and imaged  
with confocal at 10x and 60x magnification ..........................................................26 
 
Figure 3.9  Fold change comparison of TM cell’s fibronectin expression between  
tested scaffold types compared to Fibronectin expression of TM  
cells on tissue culture plate ....................................................................................27 
 
Figure 3.10 Measurement of fibronectin expression compared between scaffold  
types in the presence of Dex (n=4) ........................................................................29 
 
Figure 4.1   Confocal image of 5% GelMA scaffold printed with AnyCubic Photon  






LIST OF TABLES 
 
 
Table 3.1  Percent conversion of free amine groups compared  
















































I would like to thank Dr. Melissa Krebs for advising and supporting me throughout this 
project. I would also like to thank Dr. Matt Osmond for the hands-on training in cell culturing, 
qPCR, data analytics, rheology, and guidance with many other pieces of equipment used 
throughout the research. I would like to thank Grae Patterson for helping me with several 
projects throughout the research. I would also like to thank the rest of Krebs lab for their advice 
and support over the year.  I would like to thank my thesis committee and Quantitative 
Biosciences and Engineering Department at Colorado School of Mines for their support. Finally, 
I would like to thank my Parents, Jim and Wynde Stinson, for their constant support and love 








1.1 Glaucoma Background 
Glaucoma is currently one of the most widespread eye conditions throughout the world, 
second only to cataracts. Unlike cataracts, however, glaucoma can ultimately cause irreversible 
blindness. In the world, approximately 66.8 million people have been affected by glaucoma. In 
the United States, an estimated 4.4 million people suffer from glaucoma, of which 120,000 have 
been rendered blind1. The pathogenesis is unknown but there are several known risk factors 
associated with glaucoma: increase in blood viscosity, vasospasms, and elevated intraocular 
pressure (IOP)2–4.  
There are different variations of glaucoma that exist: primary angle closure glaucoma 
(PACG), secondary glaucoma, congenital glaucoma, normal tension glaucoma (NTG), 
pigmentary glaucoma, and primary open-angle glaucoma (POAG). POAG is the most common 
form of glaucoma making up 70% of all glaucoma cases2. POAG is typically associated with an 
increase in the IOP, the pressure of fluid inside the eye. IOP is regulated by the production and 
outflow of aqueous humor contained in the anterior chamber5. Aqueous humor, produced by the 
epithelium of the ciliary body, is responsible for delivering nutrients to cells within the eye as 
well as removing cellular waste when exiting the eye1. Its main exit is a region in the eye called 
trabecular meshwork (TM), but can also exit via another pathway that is insensitive to eye 
pressure, the uveoscleral outflow1. The TM is composed of sheets of extracellular matrix (ECM) 
with endothelial-like TM cells residing within. Inflow of aqueous humor is relatively constant 




TM6. If the TM is restricting the outflow of aqueous humor, IOP will increase. Normal IOP is 
shown to be between 15-20 mmHg. Any pressure above this can be defined as ocular 
hypertension7. It is known that a high enough increase of IOP causes permanent damage to the 
optic nerve leading to irreversible blindness. However, it is still unclear what causes this 
uncontrolled elevation of IOP1. 
1.2 Current Treatments 
There is no cure for glaucoma meaning any treatment is done only to prolong the 
symptoms to prevent irreversible blindness. The most common treatment to slow down the 
progression of the disease is lowering the IOP. This can be done by incisional surgery, laser 
surgery, or the most common method, medicinally. Medicine aims to lower IOP in two different 
ways; by either slowing the rate of aqueous humor production or increasing the rate of aqueous 
humor drainage. These medications can be divided into five major classes: prostaglandin 
analogs, beta blockers, diuretics, cholinergic agonists and alpha agonists1.  These medications 
can be further classified into several categories: topical vs oral and decreasing aqueous humor 
fluid production vs increased aqueous flow through the uveoscleral meshwork.  The POAG 
medications that increase the drainage of aqueous humor do so through uveoscleral outflow 
rather than through the TM. Because these drugs do not target the TM directly, there is not one 
that can decrease IOP by more than 25%1. The American Academy of Ophthalmology 
recommends that to effectively treat POAG, the target IOP reduction should be at least 25%1. 
The absence of drugs that target the TM is due the lack of direct knowledge about the cellular 
function and biological interaction of the cells that occur within the 3-dimensional (3D) 





1.3 In Vitro Models of Trabecular Meshwork  
The 3D complexity of the TM has been directly linked to its ability to regulate aqueous 
humor drainage. Images have been taken in situ using auto fluorescence to better observe the 3D 
environment of the TM. These images show uveal meshwork (UM), corneoscleral meshwork, 
and juxtacanalicular meshwork(JM) tissue composed of long branching beams, connective tissue 












Figure 1.1 The outflow pathway of aqueous humor in the eye. 
The uveal and corneoscleral TM is composed of densely packed collagen and elastic fiber. These 
densely packed meshworks provide resistance critical for regulating aqueous humor outflow.  
IOP will continue to build as aqueous humor accumulates until the pressure gradient is great 
enough to drive flow across the TM and through the Schlemm’s canal (SC) into the collecting 







humor. Unfortunately, there have been many challenges trying to replicate this environment 
using in vitro models. Typically, in vitro models are TM cells cultured on flat 2-dimensional 
(2D) substrates such as cell culture dishes which focus on creating environments that can more 
efficiently grow TM cells. These 2D models can provide some insight to how cells function in 
vivo. However, the 3D complexity of the native tissue is lost in typical 2D cultures. This lack of 
function makes it difficult to screen novel drugs accurately due to TM cells functioning 
differently in 3D models compared to in vivo. Some studies have been done to try and simulate 
3D environments to better study the TM. These studies have found that TM cells more accurately 
regulate apoptosis and adaptation mechanisms in 3D cultures versus 2D cultures10,11. 3D cultures 
studied to date include collagen glycosaminoglycans (GAGs) scaffolds, Matrigel, and coded SU-
8 scaffolds10–13. This study focuses on creating an optimal 3D environment via gelatin 
methacrylate (GelMA) hydrogels. 
1.4 Gelatin-Methacrylate as a 3D Substrate for TM Cell Growth 
A good model hydrogel must have certain characteristics to accurately represent a 3D in 
vivo environment. The environment must promote and support both cell-cell and cell-matrix 
interactions as well as mimicking the structure of the native tissue. The TM is composed of 
highly dense collagen with no extended structural regularity in organization14. GelMA, first 
characterized by Van Den Bulcke, is one of the most adaptable hydrogels15. GelMA is a semi-
synthetic hydrogel composed of gelatin, denatured collagen intermediates, which have been 
functionalized with a methacrylate group16. Because GelMA is composed of hydrolyzed 
collagen, it provides the TM cells with a more natural environment as well as retaining its ability 
to promote cell adhesion, proliferation, and growth17. Gelatin promotes cell attachment due to its 




presence of aromatic groups18. Gelatin itself can form a hydrogel at low temperatures and high 
enough concentrations; however, due to its poor mechanical strength it is not an optimal 
hydrogen model18. Chemical- and photo-crosslinking methods have been implemented to 
increase the strength of gelatin gels. Chemical crosslinking can be done with the addition 
compounds such as glutaraldehyde. However, most chemical crosslinking agents take time (~15 
mins.) to crosslink and have been known to be cytotoxic. Therefore, this method is not favorable 
when performing cell studies. Photo-crosslinking is a very fast and uniformed method. In order 
to make gelatin obtain the ability to photo-crosslink, it must first be functionalized with a 
methacrylate group by reacting it with methacrylic anhydride. Methacrylic anhydride molecules 
react with the lysine and hydroxyl lysine groups of gelatin to form GelMA16,18. Due to this 
methacrylation, the modified gelatin now carries the ability to support crosslinking in the 
presence of a photo initiator and a UV light source16–18.  
GAGs also have been shown to play a crucial role in physiological function of the TM. 
Studies have shown that the addition of testicular hyaluronidase, a glycosaminoglycan degrading 
enzyme, greatly decreased the outflow resistance in the TM19. Among other GAGs, chondroitin 
sulfate (CS) and hyaluronic acid (HA) have been associated with POAG19–21.  An increase in the 
amount of CS present in the aqueous humor has been shown to cause an increase in IOP as well 
as in extracellular material such as collagen fibers, elastic fibers, and fine fibrils19. Other studies 
have shown that a depletion of HA in the eye leads to a decrease in matrix metalloproteinases, 
MMP-2 and MMP-9. These proteases are responsible for the degradation of extracellular 
proteins and are necessary for normal growth and tissue turnover20. To better mimic the native 





1.5 Application of Drug Studies  
Since the TM cells can now be cultured in a biomimetic ECM environment, then it is 
possible to further examine the effect of soluble factors on their behavior. Dexamethasone (Dex), 
a corticosteroid, was chosen to be tested. Dex is commonly used in patients suffering from ocular 
inflammation; however, some patients who have taken Dex have developed ocular hypertension 
as a side effect22. Patients already suffering from POAG were found to be even more susceptible 
to Dex’s effect on IOP23,24. The presence of Dex has been shown to have impact on the 
upregulation of specific genes associated with cell adhesion, cell cycle and growth factors. One 
such gene is MYOC which codes for the production of myocilin. Although the overall 
physiological function of myocilin is unknown, research suggests that it is a key protein in 
regulating pressure within the eye. Also known as the glaucoma gene, mutations and 
overexpression of MYOC causative for development of POAG. Overexpression of myocilin has 
been shown to lead to lower outflow of aqueous humor and increased sensitivity to apoptosis as 
well as de-adhesive activity22,25. Under Dex treatment MYOC had a significant increase in 
expression levels24. Dex has been shown to influence the expression of FN1, the gene 
responsible for fibronectin production. Fibronectin is an extracellular glycoprotein and is 
involved in numerous cellular functions such as: cell adhesion, growth, and migration26. 
Fibronectin has been observed in regions of the TM as well as in Schlemm’s canal. Studies have 
observed that patients suffering from POAG have accumulations of higher average 
concentrations of fibronectin within the TM26. It is hypothesized that this too may play a role in 
increased IOP26. Studies done with Dex with respect to fibronectin have observed that 





1.6 Goal of Research 
The overall goal of this research is to create a 3D in vitro model that can more accurately 
model the TM to one day be used in therapeutic studies. In order to do this, three main steps had 
to be accomplished. The first step was to develop and test a procedure to produce GelMA and 
fabricate it into scaffolds. The second step was to determine the optimal underlying GelMA 
concentration to use and to test the mechanical strength and swelling capabilities of these 
scaffolds in the presence of GAGs. The final step was to seed TM cells onto the various GelMA 
scaffolds and study proliferation, gene expression, and cell morphology through confocal 
microscopy. 
1.6.1 Production of GelMA and Fabrication of Scaffolds 
One of the most important parts of this project was to develop a method to consistently 
produce GelMA with the same degree of methacrylation. This is necessary to ensure that results 
found from studies done on GelMA scaffolds can be compared across different GelMA batches. 
Studies were also done to determine optimal conditions of photo-initiators to ensure the optimal 
amount of crosslinking occurs to help stabilize the integrity of the scaffold without negatively 
affecting the cells. 
1.6.2 Characterizing Scaffolds 
The first step was to determine the optimal concentration (w/v%) of GelMA to use for 
each scaffold. This was determined by conducting a cell study on fabricated GelMA scaffolds at 
different weight percents and examining which condition resulted in the best cell growth for TM 
cells. It was also taken into account that higher increase of GelMA concentration would more 
closely resemble a traditional 2D environment. Once the optimal GelMA concentration was 




performed to measure the storage modulus of each fabricated scaffold condition. The final 
characterization was a 2 week study to observe the swelling of each scaffold. 
1.6.3 TM Culture on GelMA Scaffolds 
The last portion of this research was studying the affect each fabricated scaffold had on 
TM cell proliferation and interaction. Assays were utilized to measure cell viability and 
proliferation. Fluorescent confocal imaging was utilized to visualize cell migration and viability 
across scaffold types. Quantitative polymerase chain reaction (qPCR) was run to analyze gene 





















MATERIALS AND METHODS 
2.1 Materials  
Gelatin Type A, Methacrylic Anhydride, Sodium Bicarbonate, Sodium Dodecyl  Sulfate 
(SDS), Chondroitin Sulfate sodium salt from shark cartilage (CS), dexamethasone 
(Dex),Hyaluronic acid sodium salt from streptococcus (HA), lithiumphenyl-2,4,6-
trimethylbenzoyl- phosphinate (LAP), Tris(2,2’-bipyridyl)dichlororuthenium(II) hexahydrate 
(Ru(BPY)3), Sodium Persulfate, Cell Culture Gelatin type B, 50% Glutaraldehyde Solution in 
H2O, Triton X-100, Penicillin Streptomycin, Sodium Azide were all purchased from Sigma-
Aldrich ( St. Louis, MO). Phosphate buffer solution (PBS), Cy™3-Steptavidin were purchased 
from Invitrogen (Carlsbad, CA). Goat Serum was purchased from Fisher Scientific (New 
Zealand). Reagent Alcohol 200 proof was purchased from Pharmco by Greenfield Global 
(Shelbyville, KY). 1% 2,4,6-Trinitrobenzene Sulfonic Acid Picrylsulfonic Acid solution in 
methanol (TNBS) was purchased from G-Bioscience (St. Louis, MO). Hydrochloric Acid (HCl) 
was purchased from Macron Fine Chemicals (Radnor, PA). Low glucose Dulbecco’s Minimum 
Essential Medium (DMEM-LG) was purchased from HyClone (South Logan, Utah). Fetal 
Bovine Serum was purchased from Atlanta Biologicals (Flowers Branch, GA). Anti-fibronectin 
antibody (Biotin) (ab6584) was purchased from Abcam (Cambridge, UK). Goat anti-rabbit IgG 
(E0432) was purchased from Dako (Denmark). 40,6-diamidino-2-phenylindole (DAPI) was 
purchased from ThermoFisher (Waltham, MA). Human Trabecular Meshwork (TM) Cells were 





2.2 Production of GelMA  
Gelatin type A was mixed in phosphate buffer solution (PBS), pH 7.4 at 10% w/v at 50˚C 
and allowed to mix until fully dissolved. Once dissolved, 1 m of methacrylic anhydride per gram 
gelatin was slowly added to the solution at 0. 5ml/min via serological pipet. The solution was 
allowed to react for 1 hr. The solution was then transferred to 50 ml conical tubes and 
centrifuged at 500xg for 5 minutes. The supernatant was collected in a beaker. The retentate is 
composed of unreacted methacrylic anhydride and was disposed of properly. The beaker was 
then placed in a biosafety cabinet under UV light for 2 hours to kill any potential contamination. 
After those 2 hours had passed, the beaker was sealed with sterile aluminum foil and placed in 
the 4˚C refrigerator until fully gelled.  
All of the following steps were done inside a biosafety cabinet to maintain sterility. Once 
gelled, a spatula was used to break the gel into smaller pieces and scrape off all gel attached to 
the side of the beaker. The contents were then put through a series of reagent alcohol washes to 
precipitate all GelMA and remove any contaminants. First, enough reagent alcohol was added to 
fully cover the gel. It was then homogenized with a kitchen grade hand blender for three minutes. 
More reagent alcohol was then poured to bring the final volume up to 1 L.  The solution was 
homogenized again until no large chunks of gel remained. The solution was then allowed to sit 
for 3 minutes for the contents to separate out. The top liquid layer was carefully poured off into 
the waste. Next, 1 L of 80% reagent alcohol was added to the beaker and again homogenized for 
3 minutes. This time, the solution was placed through a vacuum filter using 22 um filter papers 
(Whatman™, China). Once the 80% reagent alcohol had been removed from the GelMA, it was 
put back into the beaker. Washes and vacuum filtration were then repeated with 1 L of 90% and 




37˚C incubator overnight to remove any remaining reagent alcohol via evaporation. The GelMA 
was then collected in a 50 ml conical tube and stored in a 4˚C refrigerator. 
2.3 Fourier Transform Infrared (FT-IR) Spectrum Analysis  
IR spectra were measured using a Nicolet™iN™ 10MX Infrared Imaging Microscope 
with the micro-attenuated total reflectance (ATR) attachment. Dried GelMA material was placed 
on microscope slides and the micro-ATR attachment was lowered until it touched the material. 
2.4 Free Amine Assay 
A 2,4,6-Trinitrobenzene Sulfonic Acid Picrylsulfonic Acid (TNBS) Assay (G-
Bioscience, St. Louis, MO) was used in order to determine the conversion of amine groups via 
methacrylation when reacting gelatin into GelMA. This colorimetric assay uses TNBS which 
undergoes a color change in the presence of free amine groups. By measuring the amount of free 
amine groups present in gelatin and after it has been converted to GelMA, it is possible to 
determine the degree of methacrylation that occurred. This assay acts as a control to ensure that 
each GelMA batch made is done with consistent methacrylation. The procedure used follows G-
Bioscience’s provided protocol with some variation28. First, a 0.1 mg/ml solution of GelMA, 
from different batches, was mixed in 0.1 M, pH 8.5 Sodium Bicarbonate (reaction buffer). These 
steps were also done with gelatin type A and glycine (as a positive control).  Next, 500 μl of the 
previously created solutions was transferred into their respective test tube. 250 μl of 5% TNBS 
diluted in reaction buffer was added to each test tube. The blanks were run with only reaction 
buffers and TNBS without the presence of gelatin or GelMA to account for any absorption from 
the solution itself. Once TNBS was added, each test tube was mixed and placed in an incubator 
37˚C for 2 hours. After 2 hours, the reaction was stopped by adding 250 μl 10% SDS in water 




a synergy H1 plate reader (Bio-tek Winooski, VT) each wells absorbance was measured at 335 
nm. Equation 2.1 was then used to calculate the conversion of amine groups29. 
																																	%	Conversion = 1 − .(0123415678	98:;0	<0123415678	=:56>0123415678	98:5?@6<0123415678	=:56>A                  (2.1)  
2.5 Fabrication of GelMA Scaffolds 
GelMA was weighed at and dissolved in PBS at 50˚C. The amount of GelMA added 
varied depending on the percent concentration required for that scaffold, e.g. 3%, 5%, 7%, 10% 
w/v. GelMA scaffolds containing GAGs were constructed at 5% w/v. These scaffolds were 
constructed with either 0.5% w/v HA, 0.5% w/v CS, 0.25% w/v CS and 0.25% w/v HA, or no 
GAGs present. Additionally, for cellular drug studies, 100 nM of Dex was added to un-
crosslinked material to be incorporated into the scaffold upon fabrication. Once fully dissolved, a 
photoinitiator was added to the solution. Two different photo initiators were used throughout the 
study. LAP at a concentration of 0.5% w/v or a complex of sodium persulfate 2% w/w 
(compared to wt. of GelMA in solution) and Ru(BPY)3 at a concentration of 0.313 mg 
Ru(BPY)3 per 1 mg sodium persulfate. Once the photo initiator was added to the solution, the 
beaker was covered with aluminum foil so no light could penetrate the solution due to the light 
sensitivity of the photo initiators. The solution was then allowed to continue mixing at 50˚C for 
another 10 minutes. Once mixed, the solution was ready for crosslinking. Regardless of the 
volume being crosslinked, all scaffolds were placed under a blue light operating at 405 nm for 10 
minutes. In order to keep scaffolds sterile for cell studies, all previous steps were done within a 
biosafety cabinet. Each scaffold was used after this point without any further modification. 
2.6 Culturing TM Cells on GelMA Scaffolds 
All fabrication of scaffolds was done under sterile conditions in a biosafety cabinet. 500 




allowed to crosslink for 10 minutes under blue light 405 nm. Once all the scaffolds were 
crosslinked, they were covered in 500 μl of 70% ethanol and placed under UV light for 2 hours. 
After 2 hours, the ethanol was removed for each well and each scaffold went through three PBS 
washes to remove all remaining ethanol. Each scaffold was then soaked in 500 μl of DMEM-LG 
with 10% FBS and 1% pen/strep and placed in an incubator operating at 37˚C and 5% CO2 
overnight. Prior to cell seeding, the media was aspirated off the scaffolds and TM cells were 
added to the surface in ultra-concentrated volumes (10-20 μl) so that each scaffold received 
50,000 cells. To ensure cellular integrity, no TM cells over passage of 5 were used. The scaffolds 
were incubated at 37˚C and 5% CO2 for 4 hours to promote cellular attachment to the scaffolds. 
After the 4 hours, each well received 500 μl of culture media and was returned to the incubator. 
Media was changed every 3 days. Proliferation was measured using CCK8.  
Cell proliferation of TM cells on each gel type was quantified by CCK8 (Dojindo 
Molecular Technologies, Rockville, MD) following the manufacturer's protocol. Briefly, excess 
media was aspirated out of each well and each scaffold was washed 3 times with PBS. LG-MEM 
media composed of 10% CCK8, was applied to each well at 500 μl. The scaffolds were 
incubated for 2 hours. 100 μl from each well was transferred to a 96-well plate and absorbance 
was measured at 450 nm. Absorbance of scaffolds containing cells was subtracted by absorbance 
measured from scaffolds not containing cells. This was done to account for any absorption 
caused by the scaffold. 
2.7 Rheology Analysis on GelMA Scaffolds 
Rheology analysis was performed using an AR-G2 rheometer (TA Instruments, New 
Castle, DE) using a 20 mm cross-hatched Peltier Plate geometry to test the storage modulus of 




in a circular mold composed of a 10 ml syringe (Fisherbrand, Pittsburgh, PA) with its top cut off. 
The scaffold was then transferred to the rheometer where an amplitude sweep was conducted on 
each scaffold performed at 37˚C, a frequency of 1 HZ with a strain sweep from 0.01% to 1000%. 
Analysis of each scaffold’s storage modulus was measured and compared at 1% strain. 
2.8 Swelling Characterization 
This analysis was done to measure the swelling characteristics of each gel. Each scaffold 
was initially made in a circular mold and crosslinked for 10 minutes. The scaffold was transferred 
to a pre-weighed 5 ml tube where its weight was measured. After the initial weighing, 2 ml of 0.1 
mg/ml sodium azide in PBS was added and the tubes were incubated at 37˚C. Measurements of 
wet weight and dry weight were again taken at 7 and 14 day time points. Media was removed from 
each tube prior to weighing. At day 7, media was changed and fresh media was put on the 2 week 
samples. Each scaffold was then frozen, lyophilized and weighed. The equation to calculate the 
swelling ratio is seen below. Swelling percent was calculated at day 1, 7 and 14.  
																																																			𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔	𝑅𝑎𝑡𝑖𝑜 = .MNO	PO.<RST	PO.MNO	PO. A                                             (2.2) 
2.9 Fluorescent Staining of TM Cells 
After CCK8 assay, media was removed from each well and prepared for confocal 
imaging of fibronectin using an altered protocol by Masum et al30. A quick overview, each 
scaffold was fixed in either neutral buffer formalin (10%) or 2% glutaraldehyde for 15 minutes. 
Media was aspirated and cells were permeabilized by adding 0.1% Triton X-100 in PBS, blocked 
with 1% goat serum for 15 minutes. Media was aspirated and cells were soaked in primary 
antibody fibronectin rabbit polyclonal IgG (1:400) overnight at 4 ˚C. Scaffolds were then rinsed 
with PBS and then soaked in biotinylated secondary antibody rabbit anti-goat IgG (1:100) in 1% 




streptavidin-CY3 (1:100) in PBS containing 1% goat serum and DAPI (1:1000) for 30 minutes. 
The scaffolds were then rinsed 3 times with PBS and visualized using a confocal scanning 
microscope (FBIOi-LIV Laser Scanning Microscope, Olympus, Center Valley, PA). 
2.10 RNA isolation and qPCR 
RNA was isolated from samples after 10 days. Cells were cultured on scaffolds placed in 
24 well plates with 50,000 cells initially. RNA was isolated using TRI Reagent following the 
manufacturer’s protocol. RNA quantity/purity was measured using a synergy H1 Plate Reader 
with a Take3 microplate. RNA was reverse transcribed using a High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Foster City, CA, USA). Real time PCR was used to 
measure expression of fibronectin and GAPDH (housekeeping gene). Both genes were identified 
for the species Homo sapiens. Primers were designed using Primer Blast (NCBI, Bethesda, MD, 
USA). For fibronectin, forward primer was 5’-CAA AGC AAG CCC GGT TGT TA-3’ and 
reverse primer was 5’-CAA AGC AAG CCC GGT TGT TA-3’. For GAPDH, forward primer 
was 5’-ACC ACA GTC CAT GCC AYC AC-3’ and reverse primer was sequence 5’-TCC ACC 
ACC CTG TTG CTG TA-3’. qPCR was performed on a Roche LightCycler 480 instrument 
(Roche, Basel, Switzerland) using PowerUP SYBR Green Master Mix (Applied Biosystem). The 
results were analyzed using ΔΔCt method.  
2.11 Analysis Techniques Used 
Each experiment was done with replicates of at least n=3 from which the mean and ± 
standard deviation was calculated. These data sets were then compared with 2-way ANOVA or 
One way ANOVA to test for individual comparisons. Differences between experimental groups 







RESULTS AND DISCUSSIONS  
3.1 Measuring the Degree of Methacrylation  
The purpose of these experiments was to determine if the GelMA protocol resulted in 
replicable degrees of methacrylation between different batches. Analysis was done using FT-IR 
and a free amine assay. 
3.1.1 FT-IR Spectrum Analysis 
The methacrylation of free amines present on gelatin gives GelMA its ability to crosslink 
into hydrogels. The first task of this research was to develop a repeatable protocol that produces 
GelMA with a similar degree of methacrylation across different batches. In order to initially 
visualize if methacrylation did occur, a sample from a batch of GelMA was analyzed and 
compared against the starting material, gelatin type A sample. This comparison was attempted to 












If methacrylation occurred there should be varying peaks at 3330 cm-1 (O-H and N-H 
stretching), 3076 cm-1 (N-H), 2943 cm-1 (Saturated C-H stretching) and 1680 cm-1 (Amide I)31. 
However, perhaps due to the sensitivity of this particular machine, only slight variations 
occurred at 2943 cm-1. This was not enough data to determine whether methacrylation had in fact 
occurred. Instead another method was used in order to better determine whether methacrylation 
had occurred and at what degree methacrylation. 
3.1.2 Free Amine Assay Analysis 
A free amine assay was run to measure the presence and degree of methacrylation 
between several different batches of GelMA in order to determine if the GelMA procedure was 
reproducible. The TNBS assay is a highly sensitive reaction used to quantify the free amino 
groups present within a sample. The reaction between primary amines and TNBS generates a 
chromogenic product which can be measured at 335 nm. TNBS was added to several batches of 
GelMA, all of which were compared to the initial amount of amine groups present in gelatin. If 
methacrylation of the gelatin did occur, then the GelMA products would see a decrease in overall 
chromogenic product resulting from a decrease in free amines present.  
The results did in fact show that there was a higher absorbance occurring in gelatin 
samples compared to the GelMA batches. This would suggest that methacrylation was successful 
and that each batch experienced lower absorbance due to the addition of a methacrylate group on 
what used to be a free amine. The highest conversion was shown to be 69.3% shown in batch 2 














The consistency of conversion between batches is important in order to compare 
experimental results that use separate batches in future studies. It was found that substitution 
occurred between 66.2% and 69.3% and generally speaking the degree of substitution of 80% is 
considered high substitution while 50% is considered medium32. The amount of substitution can 
greatly impact the amount of porosity present within the hydrogel. Higher porosity gels support 
the distribution of media across the matrix as well as diffusion of oxygen 33. The relationship 
between amount of substitution and porosity is inverse so it is important to want to keep 
substitution low enough to increase pore size but not high enough so the gels stability is not 
hindered33. Therefore, the degree of methacrylation obtained between batches was optimal.   
3.2 Scaffolds Characterization 
The next task was determining the optimal underlying concentration of GelMA to 
fabricate the scaffolds. Then the storage modulus and swelling ratio were measured for these 
scaffolds in the presence of GAGs at varying concentrations.  
3.2.1 Underlying GelMA Wt.% Concentration Determined 
The baseline GelMA concentration that was used in the remaining studies was 
determined by running a cell study, measuring the proliferation of TM cells on scaffolds 
Batch Number % Conversion ± Standard Deviation 
Batch 1 66.2% ± 1.5 
Batch 2 69.3% ± 2.0 




containing different concentrations of GelMA: 3%, 5%, 7%, and 10% w/v.  The goal of this 
study was to determine not only which scaffolds promote the most cellular proliferation, but also 
which gels could physically withstand a 2 weeklong experiment. The ability for the gel to 
withstand degradation over a 2 weeklong experiment is important if future drug studies are to be 
tested using said scaffolds. Proliferation studies were taken at 3, 7, and 14 days. At each time 






Figure 3.2 Proliferation of TM cells on varying concentrations of GelMA scaffolds over 3, 7 and 
14 days using CCK8. 
 
Each gel condition whether it was 5%, 7%, or 10%, all experienced similar amounts of 
proliferation during each time point. There was no significance found for proliferation between 
each gel concentration at each time point.  The scaffold containing 3% GelMA was unable to 
maintain its integrity over the 2 week experiment and therefore were not considered moving 




imaged via confocal and therefore no images of this gel exist. Each gel was fixed with 
glutaraldehyde and stained with DAPI and imaged with a confocal microscope to qualitatively 
measure the presence of TM cells on varying scaffolds (Figure 3.3). All imaged scaffolds at 
varying concentration of GelMA showed cell proliferation and healthy cellular morphology at 

















Figure 3.3 Fluorescently stained nuclei of TM cells stained with DAPI (blue) and imaged using 
confocal at 3 days, 7 days, and 14 days grown on 5%, 7%, and 10% GelMA scaffolds.  
 
Because scaffold types 5%, 7% and 10% all experienced similar proliferation, the literature 
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5% GelMA scaffolds were used in other studies due to their higher porosity compared to 
scaffolds fabricated with higher concentrations of GelMA34. A higher porosity helps support 
cellular growth by more easily providing nutrients and oxygen diffusion to the cells33. It was also 
found that 5% GelMA possessed enough mechanical strength to endure processes such as 3D 
printing, further confirming its ability to survive 2 week long cell studies35. Due to the previously 
listed features, the concentration 5% GelMA w/v was chosen to be the baseline concentration for 
all scaffolds tested throughout the following experiments: 5% GelMA (GelMA), 5% GelMA + 
0.5% CS (GelMA/CS), 5% GelMA + 0.5% HA (GelMA/HA), and 5% GelMA + CS/HA 0.25% 
each (GelMA/CS/HA). 
3.2.2 Storage Modulus Analysis of each Scaffold Type 
The material strength of each gel was measured via Rheology. The measurement of 
interest was each scaffold’s storage modulus. Storage modulus is a measurement of resistance to 
deformation of an elastic material. Each scaffold was tested (n = 4) and the average storage 


















Figure 3.4 Storage modulus of GelMA, GelMA/HA, GelMA/CS, and GelMA/CS/HA (n=4).  
 
The highest storage modulus was present in the gel containing GelMA/HA at 1258.51 Pa. 
This was expected due to HA’s high molecular weight (11.9 x 105 Da). The starting material 
itself is very viscous in the presence of HA and it appears the gel has retained some of these 
properties after crosslinking. A similar trend can be noticed in CS containing gels when 
compared to GelMA but not as severe perhaps due to CS lower molecular weight (3.48 x 105 
Da). It was found that GelMA/HA contained a significantly higher storage modulus in regard to 
all other gels. It also can be noted that the GelMA/CS/HA scaffold displayed a higher storage 
modulus when compared to scaffold GelMA/CS but not to any degree of significance. The gel 
containing the lowest storage modulus (330.97 Pa) was 5% GelMA lacking any additional 
GAGs. It appears that the inclusion of GAGs within the scaffold causes a higher stiffness and is 
also dependent on the individual GAGs size or molecular weight. 
3.2.3 Swelling Analysis  
To further characterize each scaffold type, the swelling ratio calculated at day 1, 7, and 
14. The swelling ratio is a good indication of the amount of media over time these gels uptake 
after initially fabrication (Figure 3.5).  





Figure 3.5 Swelling ratio for GelMA, GelMA/HA, GelMA/CS, and GelMA/CS/HA 
scaffolds(n=3) at 1 day, 7 days, and 14 days. 
 
After the conclusion of the experiment it was apparent that scaffolds GelMA/CS and 
GelMA/CS/HA both saw an increase in swelling at both time points. This may indicate that CS 
contributes to the swelling behavior of these gels. GelMA initially at day 7 did not see change in 
swelling but after the fresh media was added did notice an increase in swelling at day 14. 
GelMA/HA was the only scaffold type that did not experience an increase of swelling and in fact 
showed decreases at day 7 and 14. Other research has shown that the porosity of hydrogels is 
directly linked to the amount of swelling. More porosity allows more permeability which in turn 
allows for more swelling to occur inside the gel36. This would suggest that scaffold type 
GelMA/CS/HA has the largest pores while scaffold type GelMA/HA has the smallest. Further 
analysis would need to be done to confirm this hypothesis, however. 
3.3 Cell Studies  
After each scaffold type was characterized, TM cells were seeded on each to observe 


























viability were measured at 7 and 14 days via CCK8 and confocal imaging. Fibronectin 
expression was also measured at 10 days. 
3.3.1 Proliferation and Confocal Imaging Studies 
A 2 week cell study was conducted on scaffold types: GelMA, GelMA/CS, GelMA/HA, and 
GelMA/CS/HA, time points were taken at 7 and 14 days. Proliferation was analyzed with the 
CCK8 kit (Figure 3.6) and afterwards each scaffold was fixed and fluorescently stained to 











Figure 3.6 (a) Comparison of proliferation across scaffold types in the presence of Dex at week 
1. (b) Comparison of proliferation across scaffold types in the presence of Dex at week 2. 
 
After the 2 week cell proliferation study had run its course, a similar trend was apparent 
in most of the scaffold types. Regardless of the presence or lack of Dex, this corticosteroid did 
not have an impact on proliferation after two weeks. Most of the scaffold types experienced 
similar proliferation levels after two weeks; however, GelMA/CS ± Dex although experiencing 
the second most proliferation in week 1, experienced the least amount of proliferation in week 2. 
A B 




The scaffold type that experienced the most growth in week 1 was GelMA/CS/HA ± Dex. Other 
scaffold types GelMA and GelMA/HA, experienced the least growth initially after week 1 but 
were able to recover and had similar growth after week 2 compared to GelMA/CS/HA scaffolds. 
Confocal microscopy was performed on each scaffold at week 1 (Figure 3.7) and week 2 (Figure 
3.8) to better visualize fibronectin expression and cell morphology. 
Figure 3.7 TM cells seeded on each scaffold type and cultured for 1 week, then fixed and stained 
for DAPI (blue) and fibronectin (Red) and imaged with confocal at 10x and 60x magnification.  
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Figure 3.8 TM cells seeded on each scaffold type and cultured for 2 weeks, then fixed and 
stained for DAPI (blue) and fibronectin (Red) and imaged with confocal at 10x and 60x 
magnification. 
 
Confocal images were taken to confirm the presence of cells as well as the presence of 
fibronectin upon each scaffold. Images were taken at 10x and 60x magnification. These images 
indicate that proliferation and migration of TM cells, with healthy morphology, occurred on all 
scaffolds over the 2 week study.  These images also depict the relationship of the fibronectin 
matrix and the TM cells. Each scaffold showed expression of fibronectin although it was not 
GelMA GelMA + Dex 
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possible to quantitatively compare the level of expression from the image alone. In order to 
examine the actual fibronectin expression each scaffold was subjected to qPCR. 
3.3.2 Analysis of Fibronectin Expression via qPCR 
The expression of fibronectin was analyzed quantitatively using qPCR to determine 
whether fibronectin express from TM cells were influenced by the difference in scaffolds and the 
presence of 100 nM Dex. Fibronectin expression in tissue culture gelatin was found to be vastly 
greater than fibronectin expression in any other scaffold. This could be due to the fact that the 
proliferation studies showed that cells grown in tissue culture gelatin proliferated much faster 
than TM cells seeded on gelatin scaffolds. However, it could also be suggested that all scaffolds 















Figure 3.9 Fold change comparison of TM cell’s fibronectin expression between tested scaffold 
types compared to fibronectin expression of TM cells on tissue culture plates.  
 
 Analysis of the presence or lack of Dex influence on the fold change of fibronectin 
expression in some interesting findings. For GelMA scaffold there was no significant difference 




between the expressions of fibronectin. Both GelMA/CS and GelMA/HA saw a significant 
increase compared to its counterpart scaffold without the addition of Dex which is expected 
when comparing it to the literature27. However, GelMA/CS had larger fold change in its 
fibronectin expression compared to GelMA scaffold than GelMA/HA which saw a lower fold 
change. In fact, only scaffolds containing 0.5% CS noticed an increase in fold change. This is 
very interesting when examining the proliferation data at two weeks. From Figure 3.8, it can be 
observed that all scaffolds resulted in similar proliferation regardless of presence of Dex, all 
except GelMA/CS scaffolds. These scaffolds showed less overall proliferation when compared to 
the other samples. However, despite having less proliferation, these scaffolds still experienced 
the largest fold change in fibronectin expression. The literature has shown that a higher presence 
of CS has been linked to higher IOP19. It has also been shown that, that there is above average 
concentration of fibronectin present in patients suffering from POAG26. The increased amounts 
of fibronectin expression in 0.5% CS scaffold may therefore make this scaffold type a good 
model for the type of TM environment one would expect to find in patients suffering from 
POAG.   
This data also suggests a link between the presence of HA and suppression of fibronectin 
expression (Figure 3.10). Even more interesting were the scaffolds containing GelMA/CS/HA, 
which saw the inverse of the normal trend. Fibronectin expression in these scaffolds was found 
to be significantly lower in the presence of Dex compared to the same scaffolds without Dex. 
Again, when observing the proliferation data at week 2, it can be noted that the scaffolds 
containing HA had equal amounts of proliferation when compared to 5% GelMA scaffolds and 
more proliferation when compared to CS only containing scaffolds. Yet, both 0.5% HA and 















Figure 3.10 Measurement of fibronectin expression compared between scaffold types in the 


















CHAPTER 4  
CONCLUSION 
4.1 Summary  
 Overall, the purpose of this research was to create an in vitro model to help better model 
trabecular meshwork. The necessity for this model is due to the vast occurrence of glaucoma in 
today’s world. Currently, 66.8 million people suffer with glaucoma across the globe and this 
number is expected to increase in the following years. The most common form of glaucoma is 
Primary Open Angle Glaucoma which is associated with an elevated intraocular pressure due to 
buildup of aqueous humor and poor diffusion across the trabecular meshwork. Trabecular 
meshwork cells’ physiology is dependent on the morphology of their environment. This causes 
trabecular meshwork cells cultured in 2D tissue cultures to behave in a completely different 
manner than they would in vivo. This has made testing novel drugs a challenge and is the reason 
there are no drugs to treat POAG that target the trabecular meshwork. This research is aimed to 
develop a gelatin derived scaffold with the inclusions of GAGs to better mimic the environment 
of the trabecular meshwork to provide new models on which to test new glaucoma drug studies. 
 The project can be broken down into three main goals. The first goal was to develop a 
reproducible procedure to fabricate GelMA starting material from methacrylation of gelatin that 
has consistent degree of methacrylation. This was first analyzed by comparing the IR spectra of 
GelMA and comparing it to the IR spectra of gelatin. However, due to the very similar structures 
of the materials and sensitivity of the machine, the IR spectra were too similar to determine the 
degree of methacrylation that occurred.  The degree of methacrylation was instead analyzed 




GelMA all experienced similar degrees of methacrylation (66%-69%), proving that the 
procedure, when followed correctly, is reproducible. 
 The next goal of the project was to fabricate and characterize GelMA scaffolds. First, a 2 
week cell study was conducted on scaffolds containing different w/v of GelMA: 3%, 5%, 7%, 
and 10%. The goal of the study was to determine the proliferation/viability of TM cells on each 
scaffold type as well as to determine if the scaffold could survive a 2 week cell study. It was 
found that proliferation was consistent across scaffolds 5%, 7%, and 10%. Overall, 5% w/v of 
GelMA was used due to its increase porosity over the other scaffold types33,34 as well as overall 
integrity and ability to survive a two week study. The scaffolds were fabricated with the presence 
of GAGs: 0.5% w/v HA, 0.5% w/v CS and 0.25% w/v CS/HA each. A mechanical analysis was 
then run to test the storage modulus of each scaffold type. It was found that scaffolds containing 
0.5% w/v HA possessed the largest storage modulus of 1258 Pa while 5% GelMA without the 
presence of GAGs obtained the smallest at 330 Pa. When compared to literature values, it was 
found that our 5% GelMA storage modulus was very similar to other studies done testing the 
storage modulus of 5% GelMA scaffold35. Swelling analysis of each sample was run to 
determine how much media each scaffold was able to retain. It was found that scaffolds 
containing CS (0.5% CS and 0.25% CS/HA) saw the most swelling followed by 5% GelMA only 
scaffolds, and finally 0.5% HA scaffolds which in fact saw a decrease in swelling over the two 
weeks. 
 The final goal of the experiment was to measure TM proliferation and viability of TM 
cells on each scaffold type over two weeks (CCK8), as well as examining the expression 
fibronectin across each scaffold type in the presence of dexamethasone. The results showed that 




proliferation the following week. Scaffolds GelMA, GelMA/HA, and GelMA/CS/HA with or 
without Dex all experienced equal amounts of proliferation after the conclusion of the 2 week 
study. Scaffold type GelMA/CS saw the opposite of this trend and experienced its largest amount 
of proliferation the first week and very little the following week. GelMA/CS in the presence of 
Dex saw no proliferation increase after the first week. Fluorescent stains were used to visualize 
TM cells and fibronectin on each scaffold type at the conclusion of week 1 and week 2. These 
images show the migration and proliferation of TM cells with healthy morphology over the 
course of both weeks. Fibronectin expression across each scaffold was also observed. From the 
pictures alone, it appeared that scaffolds with Dex present experienced the most fibronectin 
expression following the literature trend27. This however cannot be fully concluded just by 
examining the confocal images alone. To measure fibronectin expression, qPCR was utilized. 
From qPCR it was found that scaffolds containing 0.5% CS experienced the most fibronectin 
expression although they experienced the worst proliferation overall. Another interesting result 
was scaffolds containing HA appeared to suppress the expression of fibronectin when compared 
to scaffold without GAGs fibronectin expression. An expected trend to be seen was the presence 
of Dex in scaffolds GelMA/CS and GelMA/HA resulted in a higher expression level of 
fibronectin which was expected when compared to literature trends27. GelMA saw minimum 
fluctuation of fibronectin expression in the presence of Dex, while interestingly enough, 
GelMA/CS/HA scaffolds saw a decrease of fibronectin expression when Dex was present. 
4.2 Future Works 
 To continue to better model the trabecular meshwork, future studies must continue to 
increase the level of 3D complexity at a cellular level. Previously this was done by creating a 




however, even in this model, the migration of cells through Z direction of the scaffold is limited. 
This means, that even still these models still lack the true 3D dynamic that is experienced within 
native tissue. One way to solve this issue is to physically add man made porous structures into 
the hydrogel model. One potential method to do this, is 3D printing scaffolds with porous 
structures. There are several different types of 3D printing methods that have been used to print 
biological material. The most fitting type of 3D printer would be a digital light processing (DLP) 
printer. DLP printing makes use of a liquid photopolymer resin of which can cure (crosslink) 
under a light building the print one layer at a time. This method of printing allows for very finely 
detailed prints. This is necessary if the goal is to create pores on a cellular level (approx. 100 
um). 
 Some attempts have already been made using Photon DLP Printer (Anycubic, Shenzehen, 
China) to try and fabricate a 5% GelMA scaffold with 100 μm pores. Unfortunately, because the 
Photon DLP Printer is a commercially used 3D printer, rather than a research grade DLP printer, 
these prints were unsuccessful in printing 100 μm pores. Although these prints themselves did 
not contain pores, they did reveal something interesting when examining them under a confocal 
microscope (Figure 4.1). 
 
 
















Figure 4.1 Confocal image of 5% GelMA scaffold printed with AnyCubic Photon DLP 3D 
Printer at 10x magnification. 
It appeared that due to the nature of the DLP printing method, it naturally prints a lattice 
structure on the surface of each scaffold. Although not truly porous, this lattice structure does 
provide a more complex 3D structure on which TM cells can be grown and shows the potential 
that the addition of 3D printing can provide to future in vitro models. 
4.3 Conclusion 
 This thesis details the research done in developing and testing new in vitro models of 
trabecular meshwork. Over this project three goals were achieved. The first goal was to design 
and test a protocol of the production of GelMA and ensure that it was repeatable. The second 
goal was to develop and characterize scaffolds using proliferation studies, mechanical analysis 
and swelling analysis. The final goal was to test how the inclusion of GAGs within the scaffold 
and the presence dexamethasone would influence TM cell proliferation, viability, migration, and 





of the TM. Future work will focus on adding another level of complexity to the model via 3D 
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